Timing matters: study probes speed of blood thinner in lung clot patients
NCT ID NCT06912009
First seen Jan 04, 2026 · Last updated Jun 19, 2026 · Updated 29 times
Summary
This study looks at 100 adults hospitalized in the ICU for a serious pulmonary embolism (a blood clot in the lung). Researchers want to know how long it takes for the blood thinner (unfractionated heparin) to reach a level that prevents more clots. They will also check if faster blood thinning is linked to lower death rates, fewer repeat clots, or more bleeding. The goal is to improve how doctors start and monitor this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Réanimation Médicale - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
unfractionated heparin (UFH)
What this could lead to
If successful, this could help doctors understand the best way to start blood thinners quickly in ICU patients with pulmonary embolism, potentially improving survival and reducing complications.
What could go wrong
This is a small, single-center, retrospective study, so results may not apply to all hospitals or patients. It only looks at past data, so it cannot prove cause and effect.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.